Eligible Medicare beneficiaries may now get certain GLP-1 medications for $50 per month through the Medicare GLP-1 Bridge, a new Centers for Medicare & Medicaid Services (CMS) initiative designed to expand access to innovative treatments and test the impacts of increased access to GLP-1 drugs for weight management on the Medicare program
[5] A separate Phase 3 trial, SURMOUNT-CN , tested tirzepatide in Chinese adults with obesity and reported mean weight changes of 13.6% (10 mg) and 17.5% (15 mg) versus 2.3% with placebo over 52 weeks
Moreover, these compounds help neutralize free radicals and reduce oxidative stress
References Demir S, Nawroth PP, Herzig S, Ekim Ustunel B
You can take it on the go, making it a convenient addition to your daily routine
For example, in 2023, the European Medicines Agency began investigating over 150 reports of suicidal ideation and other psychiatric symptoms linked to GLP-1 receptor agonists, including Ozempic and Wegovy